Capricor Therapeutics Inc (NASDAQ:CAPR – Get Rating) insider Xavier Avat sold 3,000 shares of the stock in a transaction that occurred on Tuesday, March 28th. The stock was sold at an average price of $4.06, for a total value of $12,180.00. Following the completion of the sale, the insider now owns 14,772 shares in the […]
/PRNewswire/ Roots Analysis has announced the addition of "Exosome Therapeutics Market, 2022-2040" report to its list of offerings. With the advancements in.
/PRNewswire/ The "Exosome Therapeutics Market by Distribution by Target Indication, Therapeutic Area, Type of Formulation, Route of Administration and.